human | Q5 |
P856 | official website | https://cris.vub.be/en/persons/sofia-ajeganova(476a9c41-74e4-49a8-b941-d02716461ae4).html |
P496 | ORCID iD | 0000-0001-9162-9717 |
P108 | employer | Vrije Universiteit Brussel | Q612665 |
P735 | given name | ??? | Q18201520 |
??? | Q18201520 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q90354326 | A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance |
Q53040856 | A four-week team-rehabilitation programme in a warm climate decreases disability and improves health and body function for up to one year: A prospective study in Swedish patients with inflammatory joint diseases. |
Q90603204 | Anti-Carbamylated Protein Antibodies and Higher Baseline Disease Activity in Rheumatoid Arthritis-A Replication Study in Three Cohorts: Comment on the Article by Truchetet et al |
Q61799672 | Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort |
Q40117130 | Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts |
Q95532931 | Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls |
Q47885394 | Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. |
Q90447550 | Autoantibody profiling reveals four protein candidate autoantigens associated with systemic lupus erythematosus |
Q35530495 | Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study. |
Q84141759 | Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study |
Q53506587 | Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms. |
Q89210029 | Disease-modifying treatment in rheumatoid arthritis: treat early and do not forget to try to taper and stop |
Q51074535 | Dr. Ajeganova and Dr. Hafström reply. |
Q39677492 | Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study. |
Q86963759 | Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis |
Q47364537 | IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors. |
Q92013870 | Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study |
Q51549596 | Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study. |
Q37704498 | Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. |
Q92670533 | Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis |
Q40502497 | Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study. |
Q51102106 | Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present. |
Q28251716 | Rheumatoid arthritis: Seronegative and seropositive RA: alike but different? |
Q89868356 | Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher pre |
Q39139958 | Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study. |
Q58234648 | The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor |
Q45106395 | The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis. |
Q33750031 | The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical. |
Q55405167 | Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study. |
Search more.